Wednesday, 26 April 2006 00:00
Company will make research grants available for qualifying physicians.
ORANGEBURG, NY – Radiancy, Inc., a global leader in light-based skin therapies, has announced the formation of the Dry Laser Peel Research Panel (DLP) in the US, to clinically evaluate current and expanded therapy applications for the company’s Whisper Extended Ablation Laser™. The new digital, hand-held erbium technology produces a “dry laser peel” that requires no anesthesia and results in virtually no downtime.
According to the company, areas of scientific investigation for the DLP will include clinical outcomes in the treatment of periorbital rhytides, the impact of extended ablation on skin types 4 & 5, the effects of the dry laser peel on collagen regeneration and the study of new therapy applications for the digital laser.
Applications to participate in the Dry Laser Peel Research Panel are now being accepted by Radiancy. The company is also providing research grants to all qualifying physicians who are accepted. To apply or for more information, please contact Margaret Fourte, Director of Clinical Affairs, Radiancy, Inc. (888) 661-2220,